Open AccessAbstract 5201: Differences in tumor microenvironments between primary lung tumors and brain metastases in lung cancer patients: Therapeutic implications for immune checkpoint inhibitors
Author(s) -
Ryul Kim,
Bhumsuk Keam,
Sehui Kim,
Miso Kim,
Se Hyun Kim,
Jin Wook Kim,
Yu Jung Kim,
Tae Min Kim,
Yoon Kyung Jeon,
Dong-Wan Kim,
Doo Hyun Chung,
Jong Seok Lee,
Dae Seog Heo
Publication year - 2018
Publication title -
cancer research
Language(s) - English
Resource type - Conference proceedings
eISSN - 1538-7445
pISSN - 0008-5472
DOI - 10.1158/1538-7445.am2018-5201
Subject(s) - medicine , pembrolizumab , metastasectomy , nivolumab , lung cancer , tumor infiltrating lymphocytes , tumor microenvironment , oncology , primary tumor , brain metastasis , lung , cancer , pathology , immunotherapy , metastasis